We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+12.12%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$2.65B
AUM Growth
+$1.2B
Cap. Flow
+$657M
Cap. Flow %
24.78%
Top 10 Hldgs %
70.55%
Holding
84
New
9
Increased
8
Reduced
22
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 50.64%
2 Financials 3.83%
3 Technology 2.66%
4 Communication Services 2.22%
5 Energy 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCON
51
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$2.01M 0.08%
1,671
-145
-8% -$163K
ATHM icon
52
Autohome
ATHM
$2.43B
$1.97M 0.07%
+81,400
New +$1.89M
AKTX
53
Akari Therapeutics
AKTX
$15.2M
$1.83M 0.07%
330
PTN
54
Palatin Technologies
PTN
$13.7M
$1.78M 0.07%
3,231
SRLP
55
DELISTED
SPRAGUE RESOURCES LP
SRLP
$844K 0.03%
39,979
GNMX
56
DELISTED
Aevi Genomic Medicine Inc
GNMX
$688K 0.03%
123,500
-725,300
-85% -$4.14M
FCSC
57
DELISTED
Fibrocell Science Inc.
FCSC
$335K 0.01%
31,045
-96,532
-76% -$1.43M
GLNG icon
58
Golar LNG
GLNG
$4.95B
-300,283
Closed -$4.65M
HALO icon
59
Halozyme
HALO
$9.72B
-500,449
Closed -$4.32M
HOUS
60
DELISTED
Anywhere Real Estate
HOUS
-365,645
Closed -$10.6M
MU icon
61
CALL
Micron Technology
MU
$1.04T
-1,700,000
Closed -$23.4M
Z icon
62
Zillow
Z
$7.04B
-665,000
Closed -$24.1M
ZG icon
63
Zillow
ZG
$7.02B
-600,000
Closed -$22M
MRTX
64
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-509,750
Closed -$2.78M
KDNY
65
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-38,391
Closed -$2.17M
SRRA
66
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-1,750
Closed -$139K
FPRX
67
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-48,582
Closed -$2.01M
MFRM
68
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
-130,738
Closed -$4.39M
CYTR
69
DELISTED
CytRx Corp
CYTR
-903,840
Closed -$12.1M
QIHU
70
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
-734,731
Closed -$53.7M

Similar funds

QVT Financial's Q3 2016 Portfolio in Review

As of Q3 2016, QVT Financial held 84 positions worth $2.65B, up 83% from $1.45B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

QVT Financial deployed $657M of net new capital in Q3 2016, opening 9 new positions and adding to 8 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.05B.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Goldman Sachs, an estimated $16M trimmed.

  • QVT Financial's largest Q3 2016 buy was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.05B.
  • QVT Financial added most to iShares Biotechnology ETF in Q3 2016, an estimated $9.58M increase.
  • QVT Financial's biggest Q3 2016 reduction was Goldman Sachs, cutting an estimated $16M.
  • QVT Financial fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $53.7M.
  • QVT Financial's ten largest holdings make up 71% of its $2.65B portfolio in Q3 2016.
  • QVT Financial opened 9 new positions and closed 13 in Q3 2016.
  • QVT Financial's portfolio value rose 83% quarter-over-quarter to $2.65B.

Based on QVT Financial's 13F filing for Q3 2016, filed 14 Nov 2016.